Related Experiment Videos
[Hereditary carcinoma: pathogenesis and diagnosis].
1Medizinische Klinik und Poliklinik I-Allgemeine Innere Medizin, Universität Bonn. m.jungck@uni-bonn.de
Zentralblatt Fur Chirurgie
|August 10, 2000
Summary
Intensive prevention programs and molecular diagnosis enable effective cancer prevention in hereditary cancer predisposition. Hereditary non-polyposis colorectal cancer (HNPCC) management involves identifying DNA mismatch repair gene mutations for targeted screening and genetic counseling.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Hereditary cancer predisposition necessitates advanced diagnostic and prevention strategies.
- Hereditary non-polyposis colorectal cancer (HNPCC) serves as a model for understanding inherited cancer syndromes.
Purpose of the Study:
- To elucidate the pathogenesis and molecular diagnosis of hereditary cancer dispositions, using HNPCC as an example.
- To highlight the role of DNA mismatch repair gene mutations in cancer development.
Main Methods:
- Germline mutation identification in DNA mismatch repair genes.
- Prescreening procedures including microsatellite instability detection and immunohistochemical tests.
- Predictive genetic testing for at-risk relatives following genetic counseling.
Main Results:
- HNPCC is an autosomal-dominant condition caused by germline mutations in DNA mismatch repair genes, significantly increasing cancer risk.
- Defective DNA mismatch repair leads to accumulation of mutations in tumor suppressor or oncogenes, driving tumorigenesis.
- HNPCC patients are at high risk for colorectal cancer and other malignancies, including renal pelvis, ureter, small bowel, and endometrial tumors.
Conclusions:
- Molecular diagnosis of germline mutations in DNA mismatch repair genes is crucial for identifying individuals at high risk for HNPCC.
- Early identification through predictive testing and inclusion in intensive prevention programs can significantly improve outcomes for HNPCC patients and their families.